ArticleBioresources and bioprocessing2025
Dairy byproducts as sustainable alternatives to FCS in 2D and 3D skeletal muscle cell cultures.
Article in Bioresources and bioprocessing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From dairy by-product to cell feed: milk whey for serum-free media and scaffold development in cell-based food production.NPJ science of food · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Skeletal muscle tissue engineering is a rapidly developing field with applications in disease modelling, tissue replacement, biorobotics, and cultivated meat. The need for more sustainable and ethical biotechnologies has grown due to concerns about resource scarcity, climate change, and animal welfare. One major challenge is replacing fetal calf serum (FCS), a widely used but ethically and environmentally highly problematic media supplement. A promising alternative is the utilization of natural byproducts such as whey and colostrum from the dairy industry, which provide essential nutrients and growth factors. In this study, wheys produced by microfiltration of raw milk and colostrum were investigated as FCS replacements for culturing C2C12 skeletal muscle cells. Composition analysis confirmed a variety of pro-proliferative compounds in both substances. Cell culture experiments led to the development of an optimized medium formulation based on colostrum whey. Colostrum whey medium (CM) supported cell proliferation and maintained the myogenic differentiation potential for over 30 days. Additionally, a CM-based freezing solution enabled effective cryopreservation throughout culture. In 3D static suspension culture, CM sustained viable spheroids for over 14 days. Spheroids showed significantly higher proliferation compared to those in serum-containing medium, making CM suitable for 3D modelling and scale-up of biomass production. These findings highlight CM as a sustainable, cost-effective, and ethical alternative for skeletal muscle tissue engineering, particularly in cultivated meat production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.